Published in Ann N Y Acad Sci on January 01, 1987
Brain behavior and immunity: twenty years of T cells. Brain Behav Immun (2007) 0.78
Cell selection by antigen in the immune response. Adv Immunol (1969) 6.05
Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med (1976) 4.63
Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction. J Exp Med (1977) 3.06
Secondary antibody responses in haptenic systems: cell population selection by antigen. J Immunol (1967) 3.01
Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells. J Exp Med (1977) 2.66
Impaired lymphocyte function in aged humans. J Clin Invest (1974) 2.32
Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A (1986) 2.27
Distribution of antibody affinities: technique of measurement. Immunochemistry (1972) 2.24
Studies on the induction of immunological unresponsiveness to pneumococcal polysaccharide in mice. J Exp Med (1966) 2.24
Studies on the control of antibody synthesis. Effect of antibody affinity upon its ability to suppress antibody formation. Immunology (1968) 2.20
Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med (1976) 2.18
Studies on the effect of the carrier molecule on antihapten antibody synthesis. I. Effect of carrier on the nature of the antibody synthesized. J Exp Med (1966) 2.16
Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology (1973) 2.07
Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest (1981) 2.04
Studies on the effect of the carrier molecule on antihapten antibody synthesis. II. Carrier specificity of anti-2,4-dinitrophenyl-poly-l-lysine antibodies. J Exp Med (1966) 1.94
Studies on the control of antibody synthesis. II. Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized. J Exp Med (1968) 1.89
Studies on the control of antibody synthesis. Interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response. J Exp Med (1967) 1.89
Ontogeny of B-lymphocyte function. I. Restricted heterogeneity of the antibody response of B lymphocytes from neonatal and fetal mice. J Exp Med (1974) 1.86
Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol (1997) 1.84
Selection of cell populations in induction of tolerance: affinity of antibody formed in partially tolerant rabbits. J Immunol (1968) 1.82
A study of the 'termination' of tolerance to BSA with DNP-BSA in rabbits: relative affinities of the antibodies for the immunizing and the paralysing antigens. Immunology (1967) 1.82
New goals for education in geriatric medicine. Ann Intern Med (1983) 1.80
Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol (1994) 1.79
The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J Clin Invest (1979) 1.67
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody. J Immunol (1968) 1.61
The autologous mixed-lymphocyte reaction. Adv Immunol (1981) 1.59
Immunological studies of Aging. III. Cytokinetic basis for the impaired response of lymphocytes from aged humans to plant lectins. J Exp Med (1977) 1.56
Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A. J Clin Invest (1979) 1.52
Isolation and characterization of antioxidative peptides from gelatin hydrolysate of Alaska pollack skin. J Agric Food Chem (2001) 1.50
Ultra-thin needle thoracoscopic surgery for hyperhidrosis with excellent cosmetic effects. Eur J Cardiothorac Surg (2000) 1.45
Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res (1997) 1.42
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer (2008) 1.41
Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1. J Immunol (1985) 1.39
Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1972) 1.39
Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas. J Exp Med (1984) 1.37
In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood (1969) 1.35
Dynamic sagittal imbalance of the spine in degenerative flat back: significance of pelvic tilt in surgical treatment. Spine (Phila Pa 1976) (2001) 1.35
Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine (1989) 1.35
Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev (1997) 1.32
Lymphocyte transformation induced by autologous cells. XII. Quantitative and qualitative differences between human autologous and allogeneic reactive T lymphocytes. J Immunol (1982) 1.30
Age-related dysregulation in CD8 T cell homeostasis: kinetics of a diversity loss. J Immunol (2000) 1.29
Synergy between human T and B lymphocytes in their response to phythaemagglutinin and pokeweed mitogen. Immunology (1976) 1.27
Studies on antigenic competition. J Exp Med (1969) 1.26
Effect of tolerance and immunity on antibody affinity. Transplant Rev (1972) 1.25
Reversible inhibition of endocytosis in cultured neurons from the Drosophila temperature-sensitive mutant shibirets1. J Neurogenet (1990) 1.25
Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol (1995) 1.25
Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy. Eye (Lond) (2013) 1.23
The effect of dose in tolerance induction on the subsequent response to a cross-reactive antigen. Immunology (1969) 1.23
Studies on the control of antibody synthesis. VI. Effect of antigen dose and time after immunization on antibody affinity and heterogeneity in the mouse. Clin Exp Immunol (1974) 1.22
Studies on immunological paralysis. I. A consideration of macrophage involvement in the induction of paralysis and immunity by type II pneumococcal polysaccharide. Clin Exp Immunol (1969) 1.22
Lymphocyte transformation induced by autologous cells. VIII. Impaired autologous mixed lymphocyte reactivity in patients with acute infectious mononucleosis. J Exp Med (1979) 1.21
Immunologic studies of aging. V. Impaired proliferation of PHA responsive human lymphocytes in culture. J Immunol (1980) 1.21
Ontogeny of B-lymphocyte function. II. Ability of endotoxin to increase the heterogeneity of affinity of the immune response of B lymphocytes from fetal mice. J Exp Med (1976) 1.18
Autologous and allogeneic stimulation of peripheral human leukocytes. Cell Immunol (1972) 1.18
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis (2005) 1.17
Surgery in thoracic esophageal perforation: primary repair is feasible. Dis Esophagus (2002) 1.16
Lymphocyte transformation induced by autologous cells: stimulation by cultured lymphoblast lines. J Clin Invest (1972) 1.15
Extraovarian granulosa cell tumor. Yonsei Med J (2001) 1.14
An evidence-based perspective on vitamin D and the growing skeleton. Osteoporos Int (2014) 1.12
Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood (2000) 1.10
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome. Clin Pharmacol Ther (1987) 1.10
Studies on the control of antibody synthesis. XII. Genetic influences on antibody affinity. Immunology (1978) 1.10
Lymphocyte transformation induced by autologous cells. III. Lymphoblast-induced lymphocyte to stimulation does not correlate with EB viral antigen expression or immunity. J Immunol (1976) 1.10
The role of circulating antibody in the control of antibody synthesis: mechanism for the suppressive effect of passive antibody on active antibody synthesis. Transfusion (1968) 1.10
Immunization of elderly people with high doses of influenza vaccine. J Am Geriatr Soc (1988) 1.09
Production of auto-anti-idiotypic antibody during the normal immune response: changes in the auto-anti-idiotypic antibody response and the idiotype repertoire associated with aging. Proc Natl Acad Sci U S A (1980) 1.09
Host defense mechanisms and aging. Semin Oncol (1989) 1.09
Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res (2001) 1.08
Granulocytic sarcoma of the uterine cervix. Int J Gynecol Cancer (2004) 1.06
Ontogeny of B-lymphocyte function. III. In vivo and in vitro studies on the ease of tolerance induction in B lymphocytes from fetal, neonatal, and adult mice. J Exp Med (1977) 1.06
Aging and arteriosclerosis. Cell cycle kinetics of young and old arterial smooth muscle cells. Am J Pathol (1988) 1.06
T cells with receptors for IgD. Nature (1985) 1.05
Aging and arteriosclerosis. I. Development of myointimal hyperplasia after endothelial injury. J Exp Med (1986) 1.05
Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. III. Absence in nu/nu mice: evidence for T-cell dependence of the anti-idiotypic-antibody response. J Exp Med (1979) 1.05
Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005). Int J Gynecol Cancer (2008) 1.04
Studies on the control of antibody synthesis. V. Effect of nonspecific modification of the magnitude of the immune response on the affinity of the antibody synthesized. J Immunol (1974) 1.03
Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med (1972) 1.03
Synthesis of Si, Mg substituted hydroxyapatites and their sintering behaviors. Biomaterials (2003) 1.02
A case of intestinal capillariasis in the Republic of Korea. Am J Trop Med Hyg (1993) 1.01
Alteration of cell-cycle regulation in epithelial ovarian cancer. Int J Gynecol Cancer (2008) 1.01
Physiology of IgD. VI. Transfer of the immunoaugmenting effect of IgD with T delta-containing helper cell populations. J Exp Med (1985) 1.01
Loss of heterozygosity in dysplasia and carcinoma of the gallbladder. Mod Pathol (1999) 1.00
Binding of antigen by immunocytes. I. Effect of ligand valence on binding affinity of MOPC 315 cells for DNP conjugates. J Exp Med (1973) 1.00
A comparison of the Farr technique with equilibrium dialysis for measurement of antibody concentration and affinity. J Immunol Methods (1975) 0.99
Ossification of the acetabular labrum. J Orthop Sci (2000) 0.99
Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. J Immunol (1988) 0.99
Vitamin D supplementation and fracture risk in adults: a new insight. Osteoporos Int (2014) 0.99